SCHEMBL3407583

SCHEMBL3407583

CCOC(=O)c1c(-c2ccc(F)cc2)nsc1C

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.64
KDM4E B2RXH2 5/20 0.64
MAPT P10636 4/20 0.64
HPGD P15428 3/20 0.64
NPC1 O15118 2/20 0.64
RAB9A P51151 2/20 0.64
NPSR1 Q6W5P4 2/20 0.64
PKM P14618 1/20 0.64
MAPK1 P28482 1/20 0.64
GRM6 O15303 1/20 0.52
PRKCZ Q05513 1/20 0.52
TRPM8 Q7Z2W7 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.48
GABRA2 P47869 1/20 0.48
GABRB2 P47870 1/20 0.48
PTGS2 P35354 1/20 0.47
TP53 P04637 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20080016 0.87 ALDH1A1 (0.49) ALDH1A1KDM4EMAPTHPGDNPC1
SCHEMBL24287864 0.86 HTT (0.57) ALDH1A1KDM4EMAPTHPGDNPC1
SCHEMBL3400194 0.86 PRKCZ (0.52) ALDH1A1KDM4EMAPTHPGDNPC1
SCHEMBL3404515 0.86 ADORA3 (0.58) ALDH1A1KDM4EMAPTHPGDNPC1
SCHEMBL13615444 0.85 POLB (0.58) ALDH1A1KDM4EMAPTHPGDNPC1
SCHEMBL13615450 0.84 TRPM8 (0.53) ALDH1A1KDM4EMAPTHPGDNPC1
SCHEMBL10941530 0.78 KDM4E (1.00) ALDH1A1KDM4EMAPTHPGDNPC1
SCHEMBL3404286 0.78 JAK2 (0.48) ALDH1A1KDM4EMAPTHPGDNPC1
SCHEMBL14711103 0.76 NPSR1 (0.40) ALDH1A1KDM4EMAPTHPGDNPC1
SCHEMBL16048570 0.76 MAPT (0.46) ALDH1A1KDM4EMAPTHPGDNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9387200-B2 Isothiazole-pyridine derivatives as modulators of HIF (hypoxia inducible factor) activity FIBROGEN, INC. (US) 2016-07-12 US disclosed
US-20150209336-A1 ISOTHIAZOLE-PYRIDINE DERIVATIVES AS MODULATORS OF HIF (HYPOXIA INDUCIBLE FACTOR) ACTIVITY FIBROGEN, INC. 2015-07-30 US disclosed
US-8952160-B2 Isothiazole-pyridine derivatives as modulators of HIF (hypoxia inducible factor) activity FIBROGEN, INC. (US) 2015-02-10 US disclosed
EP-2252619-B1 ISOTHIAZOLE-PYRIDINE DERIVATIVES AS MODULATORS OF HIF (HYPOXIA INDUCIBLE FACTOR) ACTIVITY FIBROGEN INC (US) 2013-10-09 EP disclosed
US-20100330199-A1 ISOTHIAZOLE-PYRIDINE DERIVATES AS MODULATORS OF HIF (HYPOXIA INDUCIBLE FACTOR) ACTIVITY FIBROGEN, INC. 2010-12-30 US disclosed
EP-2252619-A1 ISOTHIAZOLE-PYRIDINE DERIVATIVES AS MODULATORS OF HIF (HYPOXIA INDUCIBLE FACTOR) ACTIVITY Fibrogen, Inc. (US) 2010-11-24 EP disclosed
WO-2009089547-A1 ISOTHIAZOLE-PYRIDINE DERIVATIVES AS MODULATORS OF HIF (HYPOXIA INDUCIBLE FACTOR) ACTIVITY FIBROGEN, INC. (US) 2009-07-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100330199-A1 ISOTHIAZOLE-PYRIDINE DERIVATES AS MODULATORS OF HIF (HYPOXIA INDUCIBLE FACTOR) ACTIVITY HIF1A, HIF1AN, EGLN3 ALDH1A1 256/4885KDM4E 1095/4885MAPT 4333/4885
US-20150209336-A1 ISOTHIAZOLE-PYRIDINE DERIVATIVES AS MODULATORS OF HIF (HYPOXIA INDUCIBLE FACTOR) ACTIVITY HIF1A, HIF1AN, EGLN3 ALDH1A1 284/4885KDM4E 961/4885MAPT 4408/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.